Monthly Newsletter
Current Issue
Archives
Subscribe
About The Editor
En espaņol
Our Mission
Advisory Board
Become Involved
Learn More
Operation Gatehouse
Our Partners
En español
A.F.P.M.
  Medical Update  
Home
Neighborhood Heart Watch Newsletter
February 2003 - Volume 2, Number 8
Neighborhood Heart Watch Program Recognized
The Neighborhood Heart Watch initiative was honored by the American Heart Association for promoting greater awareness of the need for immediate access to defibrillators by placing the lifesaving units in communities throughout the country.

Grants Place AEDs in Schools
Thanks to donations from anonymous individuals, corporations, and foundations, an estimated 100,000 AED packages valued at $3,000 can be purchased by schools for as little as $750.

Gauging Your Risk-New C-Reactive Protein Guidelines
In January, the American Heart Association and the CDC issued new guidelines urging doctors to consider testing millions of Americans at moderate risk for heart disease for signs of inflammation, a painless and major trigger of heart trouble. Recent evidence suggests that high blood levels of a substance called C-reactive protein are associated with increased risk of heart attack and stroke.

HIV Therapies May Carry Health Risks
Widespread use of HIV drugs has dramatically improved the longevity and quality of life for millions of Americans infected with the virus. New studies show, however, that the long-term use of the antiretroviral agents are not without risk.

Carbohydrates and the Glycemic Index
Experts say that the glycemic index--a ranking of carbohydrate-rich foods based on their effect on blood glucose levels--may be a key weapon in combating the current epidemic of obesity, diabetes and heart disease.

IU Launches Lipid-Lowering Program
When diet, exercise, and cholesterol-lowering medications don't work, what can one do to reduce the high risk of cardiovascular disease, heart attack, and stroke? For individuals suffering from a genetically inherited disorder called familial hypercholesterolemia (FH), there is new hope. An emerging technology offers an alternative to families with this genetic predisposition to high cholesterol, or FH.

Winning Health Recipe of the Month
Hearty Mushroom Soup

Jack Gardiner: Patient Number One
In late February 1998, Jack Gardiner became the first patient in the St. Elizabeth's Coronary Gene Therapy Program trials. After a series of heart problems over the years, doctors gave him about six months to live. But he learned about Dr. Jeffrey Isner's gene therapy research and gratefully accepted the invitation to become part of the investigational study.

Inside Current Issue

This webpage uses Javascript to display some content.

Please enable Javascript in your browser and reload this page.

© COPYRIGHT 2003 AMERICAN FOUNDATION FOR PREVENTATIVE MEDICINE, ALL RIGHTS RESERVED.
National Defibrillation Program Launched
Neighborhood Heart Watch Subscriptions

Neighborhood Heart Watch Partners